| 证券代码：301017 | 证券简称：漱玉平民 | 公告编号：2026-004 | | --- | --- | --- | | 债券代码：123172 | 债券简称：漱玉转债 | | 1、审议通过《关于 2026 年度公司及子公司向银行等机构申请综合授信额度及提供担 保的议案》 董事会 同意 2026 年度公 司及子公司 拟向银行等 机构申请总额 不超过人民币 687,080.00 万元的综合授信，同时公司及子公司预计为上述综合授信额度提供不超过人民 币 145,412.17 万元的担保。授信额度及担保额度有效期自审议本议案的 2026 年第一次临 时股东会审议通过之日起十二个月。 具体授信金额、授信期限等以银行等机构实际审批为准，授信额度在授权期限内可循 环滚动使用。本次担保额度为公司及子公司对公司合并报表范围内各级子公司 2026 年度预 计发生的担保额度，其中，公司向控股子公司福州榕参医药连锁有限公司、山东漱玉康杰 药业有限公司提供全额担保；公司向其他控股子公司按照持股比例提供担保，控股子公司 其他股东将提供同比例担保。本次被担保对象为公司合并报表范围内各级子公司，经营情 况稳定，资信状况良好，公司 ...

漱玉平民公告称，近日控股股东、实际控制人李文杰部分股份办理解除质押业务，解除质押1000万股， 占其所持股份比例7.43%，占公司总股本比例2.47%，起始日为2023年11月21日，解除日期为2026年1月 19日，质权人为华能贵诚信托有限公司。截至公告披露日，李文杰及其一致行动人累计被质押股份4421 万股，占其所持股份比例20.94%，占公司总股本比例10.90%。本次解质不会导致实控权变更，对公司 无实质影响。 ...

| 证券代码：301017 | 证券简称：漱玉平民 | 公告编号：2026-007 | | --- | --- | --- | | 债券代码：123172 | 债券简称：漱玉转债 | | 漱玉平民大药房连锁股份有限公司 关于控股股东、实际控制人部分股份解除质押的公告 一、控股股东股份解除质押基本情况 | 股东 名称 | 是否为控股 股东或第一 | 本次解除质 | 占其所 持股份 | 占公司 总股本 | 起始日 | 解除日期 | 质权人 | | --- | --- | --- | --- | --- | --- | --- | --- | | | 大股东及其 一致行动人 | 押数量（股） | 比例（%） | 比例（%） | | | | | 李文杰 | 是 | 10,000,000 | 7.43 | 2.47 | 2023 年 11 | 2026 年 1 月 | 华能贵诚信托有限 | | | | | | | 月 21 日 | 19 日 | 公司 | | 合计 | — | 10,000,000 | 7.43 | 2.47 | — | — | — | （一）本次解除质押基本情况 截至 2026 年 1 月 19 日， ...

| | | 漱玉平民大药房连锁股份有限公司 关于 2026 年度公司及子公司向银行等机构 申请综合授信额度及提供担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 漱玉平民大药房连锁股份有限公司（以下简称"公司"）于 2026 年 1 月 20 日召开第四 届董事会第十六次会议，以 9 票同意、0 票反对、0 票弃权审议通过了《关于 2026 年度公 司及子公司向银行等机构申请综合授信额度及提供担保的议案》，该议案尚需提交公司股东 会审议。现将相关事项公告如下： 一、综合授信额度及担保情况概述 根据公司经营发展的需要，2026 年度公司及子公司拟向银行等机构申请总额不超过人 民币 687,080.00 万元的综合授信，同时公司及子公司预计为上述综合授信额度提供不超过 人民币 145,412.17 万元的担保。授信额度及担保额度有效期自审议本议案的 2026 年第一 次临时股东会审议通过之日起十二个月。 上述综合授信形式及用途包括但不限于贷款、国内贸易融资业务、银行承兑汇票、商 票保贴、商票贴现、国内保理、国内信用证、融资性理财、中票、短融、超短融、保 ...

Market Overview - The pharmaceutical commercial sector experienced a decline of 2.19% on January 15, with Huaren Health leading the drop [1] - The Shanghai Composite Index closed at 4112.6, down 0.33%, while the Shenzhen Component Index closed at 14306.73, up 0.41% [1] Individual Stock Performance - Notable gainers included: - RunDa Medical (603108) with a closing price of 20.04, up 1.83% and a trading volume of 700,800 shares [1] - LiuYao Group (603368) closed at 18.58, up 0.60% with a trading volume of 79,700 shares [1] - LaoBaiXing (603883) closed at 16.11, up 0.50% with a trading volume of 226,200 shares [1] - Significant decliners included: - Huaren Health (301408) closed at 23.81, down 19.99% with a trading volume of 491,100 shares [2] - ShangYu PingMin (301017) closed at 18.50, down 13.75% with a trading volume of 373,900 shares [2] - YaoYiGou (300937) closed at 37.40, down 11.79% with a trading volume of 121,400 shares [2] Capital Flow Analysis - The pharmaceutical commercial sector saw a net outflow of 990 million yuan from institutional investors, while retail investors had a net inflow of 977 million yuan [2] - The table of capital flow indicates that: - LaoBaiXing (603883) had a net inflow of 46.10 million yuan from institutional investors [3] - JiuZhouTong (600998) had a net inflow of 40.43 million yuan from institutional investors [3] - RunDa Medical (603108) had a net inflow of 37.80 million yuan from institutional investors [3]

关于调剂担保额度暨为子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、担保情况概述 漱玉平民大药房连锁股份有限公司（以下简称"公司"）于 2025 年 1 月 21 日召开第 四届董事会第三次会议，于 2025 年 2 月 6 日召开 2025 年第一次临时股东大会，审议通过 了《关于 2025 年度公司及子公司向银行等机构申请综合授信额度及提供担保的议案》，同 意公司及子公司 2025 年度对合并报表范围内各级子公司提供的担保额度为人民币 167,011.00 万元。公司于 2025 年 12 月 10 日召开第四届董事会第十四次会议，于 2025 年 12 月 26 日召开 2025 年第五次临时股东会审议通过了《关于追加 2025 年度担保额度的议案》， 该次追加担保额度后，公司及子公司为合并报表范围内各级子公司提供担保总额度为 169,011.00 万元。 公司可以根据实际情况，在上述额度范围内，在符合要求的担保对象之间可以进行担 保额度的调剂，担保额度调剂以不跨过资产负债率 70%的标准进行调剂。担保额度有效期自 202 ...

21财经1月14日电，漱玉平民(301017.SZ)公告，持股5%以上股东阿里健康科技（中国）有限公司计划在 2026年2月4日至2026年4月30日期间，通过集中竞价和/或大宗交易方式减持公司股份不超过8,107,214 股，占总股本比例不超过2%。其中，通过集中竞价交易方式减持不超过4,053,607股，通过大宗交易方 式减持不超过4,053,607股。减持后，阿里健康持股比例预计将下降至4.67%左右。 ...

Core Viewpoint - The major shareholder, Alibaba Health Technology (China) Co., Ltd., plans to reduce its stake in Shuyu Pingmin (301017) by up to 8,107,214 shares, representing 2% of the total share capital, due to personal funding needs [1][4]. Group 1: Shareholder Reduction Plans - Alibaba Health holds 27,039,100 shares, accounting for 6.67% of the company's total share capital [1]. - The reduction will occur within three months after the announcement, utilizing both centralized bidding and block trading methods [1]. - The planned reduction includes a maximum of 4,053,607 shares through centralized bidding and 4,053,607 shares through block trading, each not exceeding 1% of the total share capital [1]. Group 2: Previous Reductions - Alibaba Health previously reduced its stake by 7,040,900 shares from November 1 to December 12, 2024, with an average price of 13.53 yuan per share for centralized bidding and 11.69 yuan per share for block trading [5][6]. - The total reduction during this period accounted for 1.75% of the total share capital [5]. Group 3: Company Performance - For the first three quarters of 2025, the company reported total revenue of 7.446 billion yuan, a year-on-year increase of 5.19% [7]. - The net profit attributable to shareholders was 109 million yuan, marking a turnaround from losses [7]. - The company's stock price increased by 10.15% to 19.43 yuan per share as of January 13, 2025, with a total market capitalization of approximately 7.876 billion yuan [8].

Mergers and Acquisitions - Lianjian Technology plans to acquire 55% equity of Zhongding Testing for 101 million yuan, making it a subsidiary included in the consolidated financial statements after the transaction [1] Termination of Asset Purchase - Yaxing Chemical announced the termination of its plan to issue shares and pay cash for the acquisition of 100% equity of Shandong Tianyi Chemical, which was expected to constitute a major asset restructuring [2] Earnings Disclosure - Kanglong Chemical expects a net profit of 1.614 billion to 1.686 billion yuan for 2025, a year-on-year decrease of 6% to 10%, while revenue is projected to grow by 13% to 16% [3] - Yongyou Network anticipates a net loss of 1.3 billion to 1.39 billion yuan for 2025, reducing losses by 671 million to 761 million yuan year-on-year [4] - Dongpeng Beverage expects a net profit of 4.34 billion to 4.59 billion yuan for 2025, an increase of 1.013 billion to 1.263 billion yuan, representing a growth of 30.46% to 37.97% [5] - Pudong Development Bank forecasts a net profit of 50.017 billion yuan for 2025, a year-on-year increase of 10.52%, with revenue expected to be 173.964 billion yuan, up 1.88% [6] Shareholding Changes - Zhang Yijie, a shareholder of Jixin Technology, plans to reduce holdings by up to 969,030 shares, not exceeding 1% of the total share capital, for personal financial needs [8] - Quantum Leap, a shareholder of Zhangyue Technology, intends to reduce its stake by up to 438,900 shares, not exceeding 1% of the total share capital, due to personal needs [7] - Alibaba Health, a major shareholder of Shuyupingmin, plans to reduce its holdings by up to 810,720 shares, accounting for 2% of the total share capital, for personal financial needs [9] - Anyang Qixu, a shareholder of Xiangyu Medical, intends to reduce its stake by up to 480,000 shares, not exceeding 3% of the total share capital, due to personal financial needs [10] Risk Matters - *ST Lifang announced that its stock price has fallen below 1 yuan, which may lead to delisting due to the stock price being below par value, and it has received a notice of administrative penalty for false records in annual reports from 2021 to 2023 [11]

Group 1: Share Buybacks and Increases - Prolo Pharmaceutical's controlling shareholder plans to increase its stake by 60 million to 120 million yuan [3] - BAIC Blue Valley and some directors and executives plan to increase their holdings by 14.5 million to 16.4 million yuan [3] - Zhongju High-tech has obtained a commitment letter for a stock repurchase loan of 540 million yuan from a financial institution [3] - Haojiang Intelligent plans to use its own funds to repurchase shares for equity incentives or employee stock ownership plans [3] - Huazhi Jie intends to repurchase shares worth 30 million to 50 million yuan [3] - Nanshan Aluminum plans to repurchase shares worth 300 million to 600 million yuan for cancellation [3] Group 2: Share Reductions - New Work Group, a shareholder of Zhongxin Group, plans to reduce its stake by no more than 3% [3] - Hongqi Technology's shareholders plan to reduce their holdings by no more than 4.68% [3] - Zhejiang Yongqiang's shareholder, Xie Jianqiang, plans to reduce his stake by no more than 1.13% [3] - Xiangyu Medical's shareholder, Anyang Qixu, plans to reduce his stake by no more than 3% [3] - Shuyuan Pingmin's shareholder, Ali Health, plans to reduce his stake by no more than 2% [3] - Hongqiang Co., Ltd.'s actual controller plans to reduce no more than 2.1161 million shares, not exceeding 1% of the total share capital [3] - China Merchants Shipping's directors and executives plan to collectively reduce their holdings by no more than 648,600 shares [3] - Zhang Yijie, a shareholder of Jixin Technology, plans to reduce his stake by no more than 1% [3] - Dingjie Smart's major shareholder, Industrial Fulian, reduced its stake by 1.14% from January 9 to January 12 [3] - Zhongli Co., Ltd.'s shareholders plan to reduce their holdings by no more than 0.75% [3]